Walleye Trading LLC Seres Therapeutics, Inc. Call Options Transaction History

Walleye Trading LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 15, 2023	SELL	$4.95 - $6.09 $145,530 - $179,046	-29,400 Reduced 96.71%	1,000 $5,000
Q4 2022 Feb 14, 2023	BUY	$5.09 - $9.05 $154,736 - $275,120	30,400 New	30,400 $170,000
Q4 2021 Feb 14, 2022	SELL	$6.02 - $11.43 $4,816 - $9,144	-800 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$5.46 - $22.6 $153,426 - $635,060	-28,100 Reduced 97.23%	800 $6,000
Q2 2021 Aug 16, 2021	BUY	$18.46 - $24.36 $533,494 - $704,004	28,900 New	28,900 $689,000

Q4 2020 Feb 16, 2021	SELL	$23.25 - $37.73 $6,975 - $11,318	-300 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$3.74 - $28.74 $1,122 - $8,622	300 New	300 $8,000

100

62.7M

36.9K

476K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $89.3M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.